![]() |
市場調查報告書
商品編碼
1906935
卵磷脂:市場佔有率分析、產業趨勢與統計、成長預測(2026-2031)Lecithin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計卵磷脂市場將從 2025 年的 10.8 億美元成長到 2026 年的 11.5 億美元,到 2031 年將達到 15.4 億美元,2026 年至 2031 年的複合年成長率為 6.1%。

加工食品中天然乳化劑的日益普及、嚴格的潔淨標示法規以及藥用級磷脂滲透率的不斷提高,共同推動了卵磷脂需求的強勁成長。同時,製藥公司在藥物遞送技術和認知健康產品中對卵磷脂的廣泛應用,也推高了高純度卵磷脂的平均售價。由於向日葵卵磷脂具有非基因改造(Non-GMO)和無致敏性等特點,因此在潔淨標示配方中表現出顯著的成長勢頭。鑑於人們對基因改造成分的日益關注,北美和歐洲的食品飲料生產商正從大豆卵磷脂轉向向日葵卵磷脂。向日葵卵磷脂風味中性且磷脂含量高,使其適用於植物性乳製品、烘焙食品和糖果甜點產品。製藥業也擴大將向日葵卵磷脂應用於脂質體藥物遞送系統,而對高純度和可追溯性的需求正在推動高純度卵磷脂市場的成長。
加工食品產業正向天然乳化劑轉型,卵磷脂成為維持產品穩定性並滿足潔淨標示要求的關鍵成分。消費者對便利、保存期限長、即食食品的偏好日益成長,推動了對能夠維持產品一致性、改善質地並延長保存期限的乳化劑和穩定劑的需求。卵磷脂源自大豆、葵花籽和雞蛋等天然成分,具有乳化劑、分散劑和保濕劑等多種功能,為生產商提供了多樣化的選擇和成本效益。潔淨標示運動正在推動市場需求,鼓勵食品生產商選擇卵磷脂等天然添加劑而非合成替代品。消費者在加工包裝食品上的支出依然強勁,美國勞工統計局的預測顯示,2023年美國家庭在烘焙產品上的平均支出將達574美元。
動物營養是卵磷脂需求成長的關鍵領域,這得益於監管部門的核准以及卵磷脂在提高畜牧生產力方面已被證實的有效性。美國食品藥物管理局(FDA) 的 21 CFR 第 573 部分法規確認了卵磷脂作為動物飼料的安全性,為飼料生產商提供了清晰的法規結構,並確保了整個行業的統一實施。卵磷脂中的磷脂質能夠促進單胃動物的脂肪消化,進而提高畜牧業的生長速度和飼料轉換率。水產養殖業是卵磷脂等功能性飼料成分需求的主要驅動力。根據聯合國糧食及農業組織 (FAO) 的數據,預計 2022/23 年度全球水產養殖產量將達到 1.309 億噸,比 2020 年成長 4%,而 2020 年全球水產養殖總產量為 2.232 億噸。這種成長給飼料和動物飼料產業帶來了越來越大的壓力,促使其採用永續的植物來源替代品來取代傳統的飼料成分。
由於大豆、葵花籽和雞蛋等原料價格波動,卵磷脂市場面臨巨大的限制。這些主要原料來源易受多種因素影響,包括天氣狀況、地緣政治議題、貿易政策和供應鏈中斷。例如,美國、巴西和烏克蘭等主要產區的極端天氣和乾旱會降低作物產量,並影響卵磷脂生產所需原料的供應和成本。由於卵磷脂來自油籽加工,食用油市場的整體波動也會影響卵磷脂的價格。消費模式的變化和生質燃料法規導致大豆油和葵花籽油需求的波動,進而影響卵磷脂的供應和定價。這種波動為生產者維持穩定的成本結構和利潤率帶來了挑戰。不斷上漲的生產成本也會影響卵磷脂相對於合成乳化劑的競爭力,尤其是在價格敏感市場。
預計到2025年,大豆卵磷脂將佔64.78%的市場佔有率,這主要得益於其成熟的供應鏈和全球大豆加工基礎設施帶來的成本優勢。葵花籽卵磷脂預計將成為成長最快的原料類別,2026年至2031年的複合年成長率將達到7.65%,因為其非基因改造(非GMO)和不含致敏成分的特性符合注重健康的消費者的需求以及不斷成長的市場需求。蛋黃卵磷脂在高附加價值領域表現穩定,在需要卓越功能性的特殊應用領域,尤其是在醫藥和高階食品領域,維持其市場地位。
在供應鏈中斷影響傳統原料來源的情況下,菜籽卵磷脂已成為一種可行的替代原料,為製造商提供了更大的採購柔軟性。包括菜籽卵磷脂在內的替代原料,正透過監管部門的核准擴大市場佔有率,例如嘉吉公司獲得美國食品藥物管理局(FDA) 的「公認安全 (GRAS)」認定,使其能夠廣泛應用於有機和非基因改造產品中。
到2025年,食品級卵磷脂將佔據56.62%的市場佔有率,主要服務於加工食品業,在烘焙、糖果和乳製品領域用作乳化劑。這種成分在食品製作流程中用途廣泛。預計2026年至2031年,醫藥級卵磷脂的複合年成長率將達到9.02%,主要成長動力來自其在藥物遞送系統和營養保健品配方中日益廣泛的應用。醫藥領域的成長得益於卵磷脂已獲證實的安全性以及美國食品藥物管理局(FDA)核准的多種用途。監管部門的核准進一步增強了醫藥製劑市場的成長潛力。
隨著製造商將卵磷脂引入非傳統應用領域,其他等級的卵磷脂,包括化妝品和工業應用領域,也迎來了成長機會。美國卵磷脂公司等企業正透過開發特種衍生物,例如源自大豆卵磷脂和向日葵卵磷脂的絲胺酸,推動醫藥級卵磷脂市場的發展。這些配方符合嚴格的藥品品質標準和規範。高價值衍生物使供應商能夠在醫藥應用領域獲得溢價和更高的利潤率。
北美將繼續保持卵磷脂市場的主導地位,預計到2025年將佔35.21%的市場佔有率。這主要得益於美國食品藥物管理局(FDA)的嚴格監管,該監管鼓勵使用天然乳化劑。北美地區正透過對大豆和芥花籽油壓榨設施的大量投資以及植物性食品不斷湧入市場,來平衡其產能。消費者在膳食補充劑上的高支出推動了腦健康產品中對高品質磷脂質的需求。亞太地區預計在2026年至2031年間達到最高的複合年成長率(CAGR),達到8.38%。中國膳食補充劑產業的擴張以及印度烘焙連鎖店的擴張,正在推動對標準和高階卵磷脂產品的需求。
亞太地區預計將成為成長最快的地區,2026年至2031年間的複合年成長率將達到8.38%,這主要得益於膳食補充劑市場的擴張以及消費者可支配收入增加帶來的對高階成分的需求成長。中國膳食補充劑市場,尤其是卵磷脂在認知健康和心血管健康產品的應用,是推動該地區需求成長的主要因素。該地區龐大的加工食品製造業對具成本效益的乳化解決方案有著顯著的需求,而消費者對卵磷脂健康益處的日益關注也推動了其在各種應用領域的廣泛使用。
歐洲在銷售和價值方面均保持平衡。由於歐洲食品安全局 (EFSA) 的監管以及對基因改造生物 (GMO) 的擔憂,對葵花籽和油菜籽卵磷脂的需求正在成長。東歐的生產商在等待地緣政治問題解決的同時,正利用其靠近葵花籽產區的優勢。南美洲是主要的供應基地,這主要得益於巴西的大豆生產。中東和非洲地區由於食品加工業的擴張以及消費者對功能性成分日益成長的認知,展現出巨大的成長潛力。然而,與更成熟的市場相比,基礎設施的限制和法規結構的不完善仍然限制該地區的市場成長。
The lecithin market is expected to grow from USD 1.08 billion in 2025 to USD 1.15 billion in 2026 and is forecast to reach USD 1.54 billion by 2031 at 6.1% CAGR over 2026-2031.

Rising uptake of natural emulsifiers in processed foods, stringent clean-label regulations, and deepening penetration of pharmaceutical-grade phospholipids keep demand on a solid upward path. In parallel, pharmaceutical companies extend lecithin's reach into drug-delivery and cognitive-health products, lifting average selling prices in the high-purity segment. Sunflower lecithin is experiencing significant growth due to its non-GMO status and allergen-free properties in clean-label formulations. Food and beverage manufacturers in North America and Europe are transitioning from soy-based to sunflower-derived lecithin as consumers become more concerned about genetically modified ingredients. The neutral flavor profile and high phospholipid content of sunflower lecithin make it suitable for plant-based dairy, bakery, and confectionery products. The pharmaceutical industry is also increasing its use of sunflower lecithin in liposomal drug delivery systems, where high purity and traceability requirements drive growth in the high-purity lecithin segment.
The processed food industry is shifting toward natural emulsifiers, making lecithin an essential ingredient for maintaining product stability while meeting clean-label requirements. The increasing consumer preference for convenient, shelf-stable, and ready-to-eat food products has created a higher demand for emulsifying and stabilizing agents that maintain consistency, improve texture, and extend shelf life. Lecithin, extracted from natural sources such as soybeans, sunflower seeds, and eggs, serves multiple functions as an emulsifier, dispersing agent, and wetting agent, providing manufacturers with versatility and cost efficiency. The clean-label movement has encouraged food producers to choose natural additives like lecithin over synthetic alternatives, increasing its market demand. Consumer spending on processed and packaged foods remains strong, as evidenced by U.S. households spending an average of USD 574 on bakery products in 2023, according to the Bureau of Labor Statistics .
Animal nutrition applications represent a significant growth area for lecithin demand, supported by regulatory approvals and demonstrated benefits in livestock productivity. The Food and Drug Administration (FDA)'s 21 CFR Part 573 regulations confirm lecithin's safety for animal feed applications, providing a clear regulatory framework for feed manufacturers and ensuring consistent implementation across the industry . The phospholipid content in lecithin improves fat digestion in monogastric animals, resulting in better growth rates and feed efficiency in livestock operations. The aquaculture industry has become a major driver of demand for functional feed ingredients like lecithin. The Food and Agriculture Organization of the United Nations (FAO) reports that global aquaculture production reached 130.9 million tons in 2022/23, contributing to a total fisheries and aquaculture output of 223.2 million tons, representing a 4% increase from 2020 . This growth has increased pressure on aquafeed and animal feed industries to incorporate sustainable, plant-based alternatives to conventional feed ingredients.
The lecithin market faces significant constraints due to fluctuating raw material prices, particularly soybeans, sunflower seeds, and eggs. These primary sources are vulnerable to various factors, including weather conditions, geopolitical issues, trade policies, and supply chain disruptions. For instance, extreme weather events or droughts in major producing regions such as the United States, Brazil, or Ukraine can reduce crop yields, affecting the availability and cost of lecithin production materials. The volatility in the broader edible oil market also influences lecithin prices, as lecithin is derived from oilseed processing. Changes in soybean or sunflower oil demand, whether from shifting consumption patterns or biofuel regulations, affect lecithin supply and pricing. This instability creates challenges for manufacturers in maintaining stable cost structures and profit margins. The increased production costs also affect lecithin's competitiveness against synthetic emulsifiers, particularly in price-sensitive markets.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Soy lecithin holds a dominant 64.78% market share in 2025, supported by established supply chains and cost benefits from the global soybean processing infrastructure. Sunflower lecithin represents the fastest-growing source segment with a projected 7.65% CAGR during 2026-2031, driven by its non-GMO status and allergen-free characteristics that align with consumer health preferences and increasing market demands. Egg lecithin maintains its position in specialized applications requiring superior functionality, particularly in pharmaceutical and premium food products, while demonstrating consistent performance in high-value segments.
Rapeseed lecithin has emerged as a viable alternative during supply chain disruptions affecting conventional sources, offering manufacturers additional sourcing flexibility. Alternative sources, including canola lecithin, have expanded their market presence through regulatory approvals, such as Cargill's Food and Drug Administration (FDA) Generally Recognised as Safe (GRAS) determination, enabling broader use in organic and non-GMO formulations.
Food grade lecithin holds 56.62% market share in 2025, primarily serving the processed food industry with emulsification solutions across bakery, confectionery, and dairy applications. The ingredient demonstrates significant versatility in food processing operations. Pharmaceutical grade lecithin projects a 9.02% CAGR during 2026-2031, driven by its increasing use in drug delivery systems and nutraceutical formulations. The pharmaceutical segment expands through lecithin's proven safety profile and Food and Drug Administration (FDA) approval for various applications. The regulatory acceptance strengthens market growth potential across pharmaceutical formulations.
Additional grades, including cosmetic and industrial applications, present growth opportunities as manufacturers implement lecithin in non-traditional uses. Companies such as American Lecithin Company advance the pharmaceutical-grade segment by developing specialized derivatives, including phosphatidylserine from soy and sunflower lecithins. These formulations comply with stringent pharmaceutical quality standards and specifications. The high-value derivatives enable suppliers to benefit from premium pricing and enhanced profit margins in pharmaceutical applications.
The Lecithin Market is Segmented by Source (Soy, Sunflower, and More), by Grade (Food Grade, Pharmaceutical Grade, and Others), by Form (Liquid, Powder, and Others), by Nature (Organic, and Conventional), by Application (Food and Beverage, Animal Feed, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
North America holds a dominant 35.21% share of the lecithin market in 2025, supported by strict Food and Drug Administration (FDA) regulations favoring natural emulsifiers. The region maintains balanced capacity through significant investments in soybean and canola crushing facilities and increased plant-based food product launches. High consumer spending on supplements drives the adoption of premium phospholipids in brain-health products. Asia-Pacific demonstrates the highest growth rate with an 8.38% CAGR during 2026-2031. The expansion of China's supplement industry and India's bakery chains drives demand for both standard and premium lecithin products.
Asia-Pacific emerges as the fastest-growing region with a CAGR of 8.38% during 2026-2031, driven by expanding nutraceutical markets and rising disposable incomes that enable premium ingredient adoption. China's dietary supplement market, particularly for lecithin applications in cognitive health and cardiovascular wellness products, contributes significantly to regional demand expansion. The region's processed food manufacturing base generates substantial demand for cost-effective emulsification solutions, while increasing consumer awareness of health benefits supports premium lecithin usage in various applications.
Europe maintains a balanced approach between volume and value segments. European Food Safety Authority (EFSA) regulations and GMO concerns drive demand toward sunflower and rapeseed lecithin. Eastern European producers benefit from proximity to sunflower production regions, pending resolution of geopolitical issues. South America serves as a key supply center, leveraging Brazil's substantial soybean production. The Middle East and Africa present growth potential due to the expansion of food processing industries and rising consumer awareness of functional ingredients. However, infrastructure constraints and underdeveloped regulatory frameworks continue to limit market growth compared to mature markets.